1. Home
  2. ASPN vs AVIR Comparison

ASPN vs AVIR Comparison

Compare ASPN & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

HOLD

Current Price

$5.45

Market Cap

407.5M

ML Signal

HOLD

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$4.05

Market Cap

413.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPN
AVIR
Founded
2001
2012
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
407.5M
413.1M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
ASPN
AVIR
Price
$5.45
$4.05
Analyst Decision
Buy
Buy
Analyst Count
6
3
Target Price
$7.75
★ $9.42
AVG Volume (30 Days)
★ 882.8K
270.2K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 3.00
EPS
★ N/A
N/A
Revenue
$271,103,000.00
★ $351,367,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$24.76
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.30
$2.87
52 Week High
$8.64
$6.45

Technical Indicators

Market Signals
Indicator
ASPN
AVIR
Relative Strength Index (RSI) 50.65 25.13
Support Level $5.25 $3.34
Resistance Level $5.60 $4.46
Average True Range (ATR) 0.24 0.25
MACD -0.02 -0.10
Stochastic Oscillator 48.74 1.24

Price Performance

Historical Comparison
ASPN
AVIR

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Share on Social Networks: